NZS Capital LLC Has $77.63 Million Holdings in Danaher Co. (NYSE:DHR)

NZS Capital LLC raised its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 338,173 shares of the conglomerate's stock after purchasing an additional 16,001 shares during the period. Danaher accounts for approximately 3.3% of NZS Capital LLC's holdings, making the stock its 7th biggest holding. NZS Capital LLC's holdings in Danaher were worth $77,628,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Kentucky Retirement Systems Insurance Trust Fund increased its stake in shares of Danaher by 11.6% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock valued at $4,874,000 after acquiring an additional 2,202 shares during the last quarter. ORG Partners LLC increased its stake in Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after purchasing an additional 2,559 shares in the last quarter. Generate Investment Management Ltd acquired a new stake in Danaher in the fourth quarter worth $8,044,000. Compass Capital Management Inc. boosted its position in shares of Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock worth $54,615,000 after purchasing an additional 10,994 shares in the last quarter. Finally, Channing Global Advisors LLC increased its position in shares of Danaher by 42.8% in the 4th quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate's stock valued at $1,301,000 after buying an additional 1,698 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

Shares of Danaher stock traded down $2.43 during trading on Thursday, hitting $196.90. 3,687,430 shares of the stock were exchanged, compared to its average volume of 3,361,293. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The stock has a market capitalization of $140.92 billion, a price-to-earnings ratio of 37.29, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The company has a fifty day moving average price of $200.30 and a 200-day moving average price of $223.12. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. As a group, equities analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date was Friday, March 28th. This is a boost from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio (DPR) is currently 24.85%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on DHR. Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price on the stock in a report on Friday, March 14th. UBS Group decreased their price objective on Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Robert W. Baird dropped their target price on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Wells Fargo & Company reduced their price target on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. Finally, Jefferies Financial Group dropped their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus price target of $264.40.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.